Article: Effect of applying the new clinical and laboratory standards institute ticarcillin/clavulanic acid, piperacillin, piperacillin/tazobactam and imipenem susceptibility breakpoints for Pseudomonas aeruginosa in Hong Kong

File Download Links for fulltext
(May Require Subscription)
Supplementary
  • Basic View
  • Metadata View
  • XML View
TitleEffect of applying the new clinical and laboratory standards institute ticarcillin/clavulanic acid, piperacillin, piperacillin/tazobactam and imipenem susceptibility breakpoints for Pseudomonas aeruginosa in Hong Kong
AuthorsHo, PL1
Chow, KH1
Tse, H1
Cheng, VCC1
KeywordsAntibiotic resistance
Antibiotic sensitivity
Bacterium examination
Bacterium isolate
Disk diffusion
Issue Date2012
PublisherElsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/ijantimicag
CitationInternational journal of antimicrobial agents, 2012, v. 40 n. 3, p. 280-281 [How to Cite?]
DOI: http://dx.doi.org/10.1016/j.ijantimicag.2012.05.008
DescriptionLetters to the editor
ISSN0924-8579
2011 Impact Factor: 4.128
2011 SCImago Journal Rankings: 0.232
DOIhttp://dx.doi.org/10.1016/j.ijantimicag.2012.05.008
DC Field
Value
dc.contributor.authorHo, PL
dc.contributor.authorChow, KH
dc.contributor.authorTse, H
dc.contributor.authorCheng, VCC
dc.date.accessioned2012-09-20T07:59:09Z
dc.date.available2012-09-20T07:59:09Z
dc.date.issued2012
dc.description.naturepostprint
dc.descriptionLetters to the editor
dc.identifier.citationInternational journal of antimicrobial agents, 2012, v. 40 n. 3, p. 280-281 [How to Cite?]
DOI: http://dx.doi.org/10.1016/j.ijantimicag.2012.05.008
dc.identifier.citeulike11382096
dc.identifier.doihttp://dx.doi.org/10.1016/j.ijantimicag.2012.05.008
dc.identifier.epage281
dc.identifier.hkuros209850
dc.identifier.issn0924-8579
2011 Impact Factor: 4.128
2011 SCImago Journal Rankings: 0.232
dc.identifier.issue3
dc.identifier.pmid22795656
dc.identifier.scopuseid_2-s2.0-84864579589
dc.identifier.spage280
dc.identifier.urihttp://hdl.handle.net/10722/164415
dc.identifier.volume40
dc.languageeng
dc.publisherElsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/ijantimicag
dc.publisher.placeNetherlands
dc.relation.ispartofInternational journal of antimicrobial agents
dc.rightsNOTICE: this is the author’s version of a work that was accepted for publication in International journal of antimicrobial agents. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in International journal of antimicrobial agents, 2012, v. 40 n. 3, p. 280-281. DOI: 10.1016/j.ijantimicag.2012.05.008
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License
dc.subjectAntibiotic resistance
dc.subjectAntibiotic sensitivity
dc.subjectBacterium examination
dc.subjectBacterium isolate
dc.subjectDisk diffusion
dc.titleEffect of applying the new clinical and laboratory standards institute ticarcillin/clavulanic acid, piperacillin, piperacillin/tazobactam and imipenem susceptibility breakpoints for Pseudomonas aeruginosa in Hong Kong
dc.typeArticle
Author Affiliations
  1. The University of Hong Kong